InMed Pharmaceuticals Inc (INM)
0.303
+0.03
(+10.99%)
USD |
NASDAQ |
Apr 24, 16:00
0.267
-0.04
(-11.88%)
After-Hours: 20:00
InMed Pharmaceuticals Cash from Investing (Quarterly): -0.0093M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0093M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.0336M |
| March 31, 2023 | -0.1282M |
| December 31, 2022 | -0.50M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.7255M |
| March 31, 2022 | -0.0036M |
| December 31, 2021 | 0.306M |
| September 30, 2021 | -0.25M |
| June 30, 2021 | -0.0017M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.0009M |
| March 31, 2020 | -0.0088M |
| December 31, 2019 | 0.0549M |
| September 30, 2019 | 3.744M |
| June 30, 2019 | 1.674M |
| March 31, 2019 | -0.0781M |
| December 31, 2018 | 0.1929M |
| September 30, 2018 | -3.894M |
| June 30, 2018 | 0.0334M |
| March 31, 2018 | -1.814M |
| December 31, 2017 | -0.0285M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0036M |
| June 30, 2017 | -0.0082M |
| March 31, 2017 | -0.0114M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.027M |
| March 31, 2016 | -0.027M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.0009M |
| June 30, 2015 | -0.0001M |
| March 31, 2015 | 0.0004M |
| December 31, 2014 | -0.0052M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -0.002M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.7255M
Minimum
Jun 2022
3.744M
Maximum
Sep 2019
0.2168M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Rimrock Gold Corp | -0.0057M |
| Venus Concept Inc | -- |
| Juva Life Inc | -0.3611M |
| CEN Biotech Inc | -0.0496M |
| Lucy Scientific Discovery Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.848M |
| Cash from Financing (Quarterly) | 4.654M |
| Free Cash Flow | -6.508M |
| Free Cash Flow Per Share (Quarterly) | -0.233 |
| Free Cash Flow to Equity (Quarterly) | -1.857M |
| Free Cash Flow to Firm (Quarterly) | -1.857M |
| Free Cash Flow Yield | -478.5% |